Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.8K Buy
+32,576
New +$49.5K ﹤0.01% 1787
2025
Q2
– Sell
-18,951
Closed -$13.4K – 1532
2025
Q1
$13.4K Buy
18,951
+489
+3% +$338 ﹤0.01% 1436
2024
Q4
$14.9K Buy
18,462
+1,711
+10% +$1.57K ﹤0.01% 1437
2024
Q3
$16.6K Buy
16,751
+890
+6% +$1.22K ﹤0.01% 1383
2024
Q2
$24.6K Buy
+15,861
New +$24.7K ﹤0.01% 1302
2023
Q2
– Sell
-12,360
Closed -$10.5K – 1281
2023
Q1
$10.5K Hold
12,360
– – ﹤0.01% 1230
2022
Q4
$16.1K Buy
12,360
+382
+3% +$595 ﹤0.01% 1220
2022
Q3
$21K Buy
11,978
+452
+4% +$1.13K ﹤0.01% 1180
2022
Q2
$26K Buy
+11,526
New +$27.6K ﹤0.01% 1173
2021
Q3
– Sell
-10,111
Closed -$81K – 1214
2021
Q2
$81K Buy
+10,111
New +$85.3K ﹤0.01% 1219

Other funds holding OCGN

Xponance's OCGN Position: Q2 2026 in Review

Xponance opened a new position in Ocugen (OCGN) in Q2 2026: 32,576 shares worth $49.8K. The stake represents ﹤0.01% of the portfolio and ranks #1787 among its holdings. This is a return to the name: Xponance previously reported a position in OCGN as recently as Q1 2025.

Xponance first reported a position in OCGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $81K in Q2 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Xponance held 32,576 shares of Ocugen worth $49.8K as of Q2 2026.
  • Ocugen was a new Xponance position in Q2 2026.
  • Ocugen made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1787 holding.
  • Xponance first reported a position in Ocugen in Q2 2021 and has held it in 10 quarters since.
  • Xponance's Ocugen position peaked at $81K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.